A Clinical Study to Determine What Effect the EyeCool Treatment Has on the Eye's Surface Anatomy and Inflammation Response After Being Treated for Having Chronic Ocular Surface Pain (COSP)
Recruiting
N/AInterventional Study
Eye Pain
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
22 – 90
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
5 (estimated)
Sponsor
EyeCool Therapeutics, Inc. · Industry
Who this trial is looking for
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
The goal of this clinical trial is to understand what effect a cold treatment with an investigational device, ETX-4143, has on the anatomical structures and the inflammatory response of the surface of the eye in those people who suffer from chronic ocular surface pain (COSP). The trial will also tell us more about the safety of this investigational device. The main questions this study aims to ans…
The goal of this clinical trial is to understand what effect a cold treatment with an investigational device, ETX-4143, has on the anatomical structures and the inflammatory response of the surface of the eye in those people who suffer from chronic ocular surface pain (COSP). The trial will also tell us more about the safety of this investigational device. The main questions this study aims to answer are:
* What anatomical changes happen to corneal surface nerves after treatment with ETX-4143
* What changes in inflammatory mediators and cell response take place after treatment with ETX-4143
Researchers will obtain images of the corneal surface nerves for analysis using a confocal microscope and collect tear bio samples for analysis.
Participants will:
* Be screened for having chronic ocular surface pain
* Will be treated with ETX-4143 cold treatment for 4 minutes
* Fill out a weekly questionnaire on eye pain for 12 weeks
* Be seen in the clinic 2 weeks, 6 weeks, and 12 weeks after treatment to have images of the corneal surface taken, and to collect a tear bio sample
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* Documented symptoms of COSP pain for at least 3 months
* A score of ≥5 on the single question COP-Q Eye Pain Severity Module
* Able to obtain sufficient quality corneal in-vivo confocal microscopy images
Exclusion Criteria:
* Less than 50% improvement in VAS Eye Pain score a…
Inclusion Criteria:
* Documented symptoms of COSP pain for at least 3 months
* A score of ≥5 on the single question COP-Q Eye Pain Severity Module
* Able to obtain sufficient quality corneal in-vivo confocal microscopy images
Exclusion Criteria:
* Less than 50% improvement in VAS Eye Pain score after topical 0.5% proparacaine hydrochloride at screening
* Subjects with clinically significant corneal scarring that could limit the confocal microscopy
* Insufficient number of corneal nerves to permit Fun-IVCM imaging
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.